We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+27.79%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$7.1B
AUM Growth
+$4.71B
(+197%)
Cap. Flow
+$3.74B
Cap. Flow
% of AUM
52.72%
Top 10 Holdings %
Top 10 Hldgs %
42.13%
Holding
1,020
New
424
Increased
501
Reduced
44
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$529M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$467M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$172M |
| 4 |
Microsoft
MSFT
|
+$124M |
| 5 |
Apple
AAPL
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$266M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$122M |
| 3 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$29.4M |
| 4 |
Idexx Laboratories
IDXX
|
+$3.65M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$3.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.57% |
| 2 | Financials | 13.35% |
| 3 | Energy | 3.93% |
| 4 | Healthcare | 3.4% |
| 5 | Real Estate | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
526
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.06M | 0.02% |
9,321
+5,207
| +127% | +$505K |
|
527
Ligand Pharmaceuticals
LGND
$5.76B
| $1.06M | 0.02% |
15,217
+8,242
| +118% | +$523K |
|
528
BioCryst Pharmaceuticals
BCRX
$2.28B
| $1.06M | 0.01% |
222,617
+205,417
| +1,194% | +$820K |
|
529
Coherus Oncology
CHRS
$217M
| $1.06M | 0.01% |
59,385
+45,524
| +328% | +$771K |
|
|
BHVN
530
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.06M | 0.01% |
14,471
+7,631
| +112% | +$406K |
|
|
LSI
531
DELISTED
Life Storage, Inc.
LSI
| $1.05M | 0.01% |
16,662
+11,412
| +217% | +$708K |
|
|
FLIR
532
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $1.05M | 0.01% |
+25,959
| New | +$1.08M |
|
|
DCPH
533
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.05M | 0.01% |
+17,618
| New | +$942K |
|
534
Cousins Properties
CUZ
$5.19B
| $1.05M | 0.01% |
+35,224
| New | +$1.06M |
|
535
AeroVironment
AVAV
$7.56B
| $1.04M | 0.01% |
+13,011
| New | +$838K |
|
|
MNTA
536
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.02M | 0.01% |
+30,766
| New | +$980K |
|
|
KYNB
537
Kyntra Bio
KYNB
$27.2M
| $1.01M | 0.01% |
1,001
+747
| +294% | +$694K |
|
538
Acadia Pharmaceuticals
ACAD
$4.43B
| $1.01M | 0.01% |
20,835
+10,427
| +100% | +$501K |
|
539
Lennar Class B
LEN.B
$19.4B
| $1.01M | 0.01% |
+23,018
| New | +$870K |
|
|
APLS
540
DELISTED
Apellis Pharmaceuticals
APLS
| $1.01M | 0.01% |
30,819
+22,557
| +273% | +$724K |
|
541
Moderna
MRNA
$21.8B
| $1M | 0.01% |
15,657
-3,490
| -18% | -$191K |
|
542
United Therapeutics
UTHR
$25.8B
| $1M | 0.01% |
8,271
+3,127
| +61% | +$352K |
|
543
BOK Financial
BOKF
$8.58B
| $1M | 0.01% |
+17,712
| New | +$907K |
|
544
Erie Indemnity
ERIE
$12.7B
| $996K | 0.01% |
+5,189
| New | +$913K |
|
545
Euronet Worldwide
EEFT
$2.72B
| $991K | 0.01% |
+10,345
| New | +$956K |
|
546
Editas Medicine
EDIT
$396M
| $990K | 0.01% |
+33,474
| New | +$875K |
|
547
Baxter International
BAX
$13.5B
| $986K | 0.01% |
11,446
+7,549
| +194% | +$658K |
|
548
Tradeweb Markets
TW
$21.4B
| $985K | 0.01% |
+16,950
| New | +$976K |
|
|
EXAS
549
DELISTED
Exact Sciences
EXAS
| $984K | 0.01% |
11,322
+5,837
| +106% | +$466K |
|
550
PTC Therapeutics
PTCT
$5.64B
| $984K | 0.01% |
19,391
+12,361
| +176% | +$607K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Rafferty Asset Management held 1,020 positions worth $7.1B, up 197% from $2.39B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Rafferty Asset Management deployed $3.74B of net new capital in Q2 2020, opening 424 new positions and adding to 501 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 3,402,773 shares worth $178M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 18% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was VanEck Junior Gold Miners ETF, an estimated $266M trimmed.
- Rafferty Asset Management's largest Q2 2020 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 3,402,773 shares worth $178M.
- Rafferty Asset Management added most to iShares Russell 2000 ETF in Q2 2020, an estimated $529M increase.
- Rafferty Asset Management's biggest Q2 2020 reduction was VanEck Junior Gold Miners ETF, cutting an estimated $266M.
- Rafferty Asset Management fully exited Cable One in Q2 2020, selling an estimated $2.84M.
- Rafferty Asset Management's ten largest holdings make up 42% of its $7.1B portfolio in Q2 2020.
- Rafferty Asset Management opened 424 new positions and closed 50 in Q2 2020.
- Rafferty Asset Management's portfolio value rose 197% quarter-over-quarter to $7.1B.
Based on Rafferty Asset Management's 13F filing for Q2 2020, filed 7 Aug 2020.